Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cell Source, Inc. | Director | Common Stock | 1.13M | $846K | $0.75 | Jun 30, 2021 | Indirect |
Cell Source, Inc. | Director | Director Stock Option (Right to Buy) | 300K | Aug 20, 2020 | Indirect | ||
Cell Source, Inc. | Director | Series A Convertible Preferred Stock | 7.89K | May 7, 2019 | Indirect | ||
Cell Source, Inc. | Director | Director Stock Option (Right to Buy) | 0 | Aug 20, 2020 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLCS | Cell Source, Inc. | Jun 30, 2021 | 1 | $3.65K | 4 | Jul 7, 2021 | Director |
CLCS | Cell Source, Inc. | May 18, 2017 | 12 | $121K | 4 | Jun 10, 2021 | Director |